The global Leukemia Screening Market is estimated to be valued at US$17.04 billion in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Leukemia screening is a vital diagnostic tool used for the early detection and monitoring of leukemia, a type of blood cancer. The market for...